DRI Healthcare delays London flotation, blaming Covid-19 meltdown

DRI_Covid_PA_575_375
By Aidan Gregory
28 Feb 2020

DRI Healthcare, the Canadian investment fund focused on pharmaceutical royalties, has postponed its $350m IPO on the London Stock Exchange, blaming the global equity market selloff caused by the spread of the Covid-19 virus.

“The IPO has been very well received by a large number of institutional investors and discretionary wealth managers,” said DRI Healthcare, in a regulatory filing on Friday. “However, in light of current volatile market conditions, the board believes it is investors' interests to extend the timetable. ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial